Strategies for the comprehensive treatment of gastric cancer ovarian metastasis

doi:10.5306/wjco.v16.i6.106589

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=0

Jun 24, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Jun 24, 2025; 16(6): 106589
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106589

Strategies for the comprehensive treatment of gastric cancer ovarian metastasis

Si-Jia Wu, Chu-Ying Wu, Kai Ye

Si-Jia Wu, Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China

Chu-Ying Wu, Kai Ye, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China

Co-first authors: Si-Jia Wu and Chu-Ying Wu.

Author contributions: Wu SJ and Wu CY contributed equally to the study; Wu SJ contributed to original draft preparation, writing, and review; Wu CY contributed to writing, review, and editing; Y Kai contributed to conceptualization, supervision, and funding acquisition; All authors have read and agreed to the published version of the manuscript.

Supported by Quanzhou Science and Technology Plan Projects, No. 2024NY033; and Fujian Provincial Health and Youth Research Project, No. 2022QNA066.

Conflict-of-interest statement: All authors report no conflicts of interest.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Kai Ye, MD, PhD, Associate Professor, Chief Physician, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, No. 950 Donghai Street, Quanzhou 362000, Fujian Province, China. medwcy@163.com

Received: March 4, 2025
Revised: March 27, 2025
Accepted: May 7, 2025
Published online: June 24, 2025
Processing time: 110 Days and 17.4 Hours

Core Tip

Core Tip: Gastric cancer incidence is currently increasing, and treatments such as gastrectomy and D2 Lymphadenectomy are utilised for resectable patients, with chemotherapy, targeted therapy, or immunotherapy being used for advanced/metastatic patients. Krukenberg tumours (ovarian metastases in females with gastric cancer) were once incurable but are now primarily treated with surgery and chemotherapy. Individualised regimens are key to improving outcomes. This review outlines strategies for treating ovarian metastasis from gastric cancer.